258830 — Sejong Medical Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Sejong Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16,230 | 15,098 | 17,241 | 16,083 | 17,992 |
Cost of Revenue | |||||
Gross Profit | 10,228 | 7,880 | 7,902 | 8,188 | 9,516 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13,098 | 16,169 | 20,415 | 22,188 | 25,712 |
Operating Profit | 3,132 | -1,071 | -3,174 | -6,105 | -7,720 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,704 | -115 | -5,813 | -91,272 | -25,393 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,063 | 455 | -6,370 | -91,491 | -23,087 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,464 | 470 | -5,192 | -91,982 | -23,087 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,464 | 470 | -5,192 | -91,982 | -23,087 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 120 | 25.7 | -142 | -2,073 | -329 |
Dividends per Share |